Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome wide expression profiles (RNAseq) of human CD8+ T cells in resting, activated (CD3+CD28) and PD-1-stimulated cells (CD3+CD28+PD-L1-Fc) at diferent time points

ABSTRACT: Genome wide expression profiles (RNAseq) of human CD8+ T cells in resting, activated (CD3+CD28) and PD-1-stimulated cells (CD3+CD28+PD-L1-Fc) at diferent time points

PROVIDER: PRJNA503833 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8157230_1.fastq.gz	Fastqsanger.gz
	SRR8157230_2.fastq.gz	Fastqsanger.gz
	SRR8157240_1.fastq.gz	Fastqsanger.gz
	SRR8157240_2.fastq.gz	Fastqsanger.gz
	SRR8157231_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 42

Similar Datasets

Genome wide expression profiles (RNAseq) of human CD8+ T cells in resting, activated (CD3+CD28) and PD-1-stimulated cells (CD3+CD28+PD-L1-Fc) at diferent time points

Project description:Background: Binding of the programmed death-1 (PD-1) receptor to its ligands (PD-L1/2) transduces inhibitory signals that promote exhaustion of activated T cells. Blockade of the PD 1 pathway is widely used for cancer treatment, yet the inhibitory signals transduced by PD-1 in T cells remain elusive. Methods: Expression profiles of human CD8+ T cells in resting, activated (CD3+CD28) and PD-1-stimulated cells (CD3+CD28+PD-L1-Fc) conditions were evaluated by RNA-seq. Bioinformatic analyses were used to identify signaling pathways differentially regulated in PD 1-stimulated cells.

2019-05-29 | GSE122149 | GEO

CD28 region-capture HiC of resting and anti-CD3/CD28-stimuated Jurkat cells

Project description:CD28 region-capture HiC of resting and anti-CD3/CD28-stimuated Jurkat cells

| PRJNA1162471 | ENA

ChIP-seq of resting and anti-CD3/CD28-stimuated Jurkat cells

Project description:To finely dissect the dynamic changes in the epigenome and chromatin state during T cell activation, we utilized the Jurkat cell line as a model and performed ChIP-seq on both resting and anti-CD3/CD28-stimulated Jurkat cells, targeting various histone modifications (H3K27ac, H3K4me1, H3K4me3, H3K27me3), RNA PolII, and CTCF.

2025-09-01 | GSE277460 | GEO

ATAC-seq of resting and anti-CD3/CD28-stimuated Jurkat cells

Project description:The majority of genetic risk variants associated with autoimmune diseases are located in chromatin regions that are accessible during T cell stimulation. To systematically investigate the dynamic changes in chromatin accessibility during T cell activation, we utilized the Jurkat cell line as a model and performed ATAC-seq on both resting and anti-CD3/CD28-stimulated Jurkat cells.

2025-09-01 | GSE276690 | GEO

CD3/CD28 signaling, Jurkat E6.1, time course 27 mins

Project description:Fe-IMAC phosphoproteomics using TMT 11plex for quant, of Jurkat T cells stimulated with CD3 and CD28 agonist antibodies for 0, 3, 9, or 27 minutes.

| MSV000092965 | MassIVE

4C-seq of resting and anti-CD3/CD28-stimuated Jurkat cells

Project description:4C-seq of resting and anti-CD3/CD28-stimuated Jurkat cells

| PRJNA1162467 | ENA

Multi-omics of resting and anti-CD3/CD28-stimuated Jurkat cells

Project description:Multi-omics of resting and anti-CD3/CD28-stimuated Jurkat cells

| PRJNA1206166 | ENA

ATAC-seq of resting and anti-CD3/CD28-stimuated Jurkat cells

Project description:ATAC-seq of resting and anti-CD3/CD28-stimuated Jurkat cells

| PRJNA1158708 | ENA

ChIP-seq of resting and anti-CD3/CD28-stimuated Jurkat cells

Project description:ChIP-seq of resting and anti-CD3/CD28-stimuated Jurkat cells